Literature DB >> 29313266

Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review.

Kendra J Kamp1, Kelly Brittain2.   

Abstract

Inflammatory bowel disease (IBD) is a chronic illness with periods of varying disease activity called flares and remissions. Since IBD impacts quality of life, patients make IBD disease management decisions every day. Previous research indicates limited insight about factors that influence decisions regarding disease management and the types of decisions IBD patients make. The purpose of this integrative review is to identify types of treatment and non-treatment decisions and the factors that influence decision making regarding disease management among individuals with IBD. An integrative literature review was performed based on the Whittemore and Knafl framework. PubMed, Web of Science, and PsychINFO were searched for relevant articles, from 2010-2016, using the key terms: decision making, patient preferences, self-management, self-care, nutrition, diet, stress, symptom, Colitis, Crohns, and IBD. Twenty-eight articles met the inclusion criteria. From these, research showed two types of decisions: treatment decisions related to medication and surgery, and non-treatment decisions focused on diet modification. Five themes that influence decisions were identified: experiencing symptoms, provider recommendations, convenience attributes, psychosocial factors, and informational needs. Most of the studies found a positive relationship between an increased number of symptoms and a patient's willingness to engage in treatment decisions. Although support from providers is highly influential for treatment decisions, most studies reported that provider recommendations did not align with patient preferences. Future work is needed to understand factors that influence decisions among recently diagnosed patients, to focus on non-treatment-related decisions, and to clarify the role of psychosocial factors in promoting disease decision making among IBD patients. This integrative review identified that, for patients, experiencing symptoms is the most important factor that influences treatment and non-treatment decisions.

Entities:  

Mesh:

Year:  2018        PMID: 29313266     DOI: 10.1007/s40271-017-0294-0

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  44 in total

1.  Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn's disease management.

Authors:  F Reed Johnson; Brett Hauber; Semra Özdemir; Corey A Siegel; Steven Hass; Bruce E Sands
Journal:  J Manag Care Pharm       Date:  2010-10

Review 2.  Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies.

Authors:  Margot L Herman; Sunanda V Kane
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

3.  Proximity to disease and perception of utility: physicians' vs patients' assessment of treatment options for ulcerative colitis.

Authors:  Lindsay Kennedy Brown; Akbar K Waljee; Peter D R Higgins; Jennifer F Waljee; Arden M Morris
Journal:  Dis Colon Rectum       Date:  2011-12       Impact factor: 4.585

Review 4.  A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis.

Authors:  Daniel M Baker; Jack H Marshall; Matthew J Lee; Georgina L Jones; Steven R Brown; Alan J Lobo
Journal:  Inflamm Bowel Dis       Date:  2017-08       Impact factor: 5.325

5.  Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients' preferences.

Authors:  Welmoed K van Deen; Dominic Nguyen; Natalie E Duran; Ellen Kane; Martijn G H van Oijen; Daniel W Hommes
Journal:  Qual Life Res       Date:  2016-08-31       Impact factor: 4.147

6.  Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations.

Authors:  Laurent Peyrin-Biroulet; Sanna Lönnfors; Xavier Roblin; Silvio Danese; Luisa Avedano
Journal:  J Crohns Colitis       Date:  2016-07-31       Impact factor: 9.071

7.  Patient perceptions of fecal microbiota transplantation for ulcerative colitis.

Authors:  Stacy A Kahn; Ashley Vachon; Dylan Rodriquez; Sarah R Goeppinger; Bonnie Surma; Julia Marks; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

8.  Patient preferences for surgical versus medical therapy for ulcerative colitis.

Authors:  Meenakshi Bewtra; Vikram Kilambi; Angelyn O Fairchild; Corey A Siegel; James D Lewis; F Reed Johnson
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

9.  A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study.

Authors:  Jessica N Cohan; Elissa M Ozanne; Justin L Sewell; Rebecca K Hofer; Uma Mahadevan; Madhulika G Varma; Emily Finlayson
Journal:  Dis Colon Rectum       Date:  2016-06       Impact factor: 4.585

10.  Patient and clinician preferences for surgical and medical treatment options in ulcerative colitis.

Authors:  C M Byrne; K-K Tan; J M Young; W Selby; M J Solomon
Journal:  Colorectal Dis       Date:  2014-04       Impact factor: 3.788

View more
  7 in total

1.  Self-Management Through Social Support Among Emerging Adults With Inflammatory Bowel Disease.

Authors:  Kendra J Kamp; Zhehui Luo; Amanda Holmstrom; Barbara Given; Gwen Wyatt
Journal:  Nurs Res       Date:  2019 Jul/Aug       Impact factor: 2.381

2.  Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease.

Authors:  Hua Fan; Juan Du; Xia Liu; Wei-Wei Zheng; Ze-Hao Zhuang; Cheng-Dang Wang; Rui Gao
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

3.  A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective.

Authors:  Edouard Louis; Juan M Ramos-Goñi; Jesus Cuervo; Uri Kopylov; Manuel Barreiro-de Acosta; Sara McCartney; Greg Rosenfeld; Dominik Bettenworth; Ailsa Hart; Kerri Novak; Xavier Donnet; David Easton; Roberto Saldaña; Katja Protze; Eyal Tzur; Gabriela Alperovich; Francesc Casellas
Journal:  Patient       Date:  2020-06       Impact factor: 3.883

4.  Reconstruction of individual, social, and professional life: Self-management experience of patients with inflammatory bowel disease.

Authors:  Seyed Mostafa Mohsenizadeh; Zahra Sadat Manzari; Hassan Vossoughinia; Hossein Ebrahimipour
Journal:  J Educ Health Promot       Date:  2021-11-30

5.  Patients' views of shared decision making in inflammatory bowel disease: a survey in China.

Authors:  Dingting Xu; Hanyun Zhang; Yan Chen
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-06       Impact factor: 2.796

6.  A patient-led, peer-to-peer qualitative study on the psychosocial relationship between young adults with inflammatory bowel disease and food.

Authors:  Jenna Rines; Kim Daley; Sunny Loo; Kwestan Safari; Deirdre Walsh; Marlyn Gill; Paul Moayyedi; Aida Fernandes; Nancy Marlett; Deborah Marshall
Journal:  Health Expect       Date:  2022-04-05       Impact factor: 3.318

7.  The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping review.

Authors:  F Pagnini; G Graffigna; E Volpato; C Bosio; E Previtali; S Leone; A Armuzzi
Journal:  BMC Gastroenterol       Date:  2021-07-14       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.